Alteral Therapeutics ApS 13D and 13G filings for NORDICUS PARTNERS CORP.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-10 2:04 pm Sale |
2024-11-12 | 13D | NORDICUS PARTNERS CORP. NORD |
Alteral Therapeutics ApS | 5,296,131 30.810% |
-7,356,148 (-58.14%) |
Filing |
| 2024-11-13 11:02 am Unchanged |
2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD |
Alteral Therapeutics ApS | 12,652,279 13.000% |
0 (Unchanged) |
Filing |
| 2024-11-05 3:10 pm Unchanged |
2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD |
Alteral Therapeutics ApS | 12,652,279 13.000% |
0 (Unchanged) |
Filing |
| 2024-06-05 4:49 pm Purchase |
2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD |
Alteral Therapeutics ApS | 12,652,279 13.000% |
12,652,279 (New Position) |
Filing |